<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>LENUS Collection:</title>
    <link>http://hdl.handle.net/10147/223265</link>
    <description />
    <pubDate>Sat, 25 May 2013 04:14:45 GMT</pubDate>
    <dc:date>2013-05-25T04:14:45Z</dc:date>
    <item>
      <title>Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.</title>
      <link>http://hdl.handle.net/10147/270372</link>
      <description>Title: Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Authors: Alazzam, Mo'iad; Tidy, John; Osborne, Raymond; Coleman, Robert; Hancock, Barry W; Lawrie, Theresa A
Abstract: Gestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.</description>
      <pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/270372</guid>
      <dc:date>2012-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>First-line chemotherapy in low-risk gestational trophoblastic neoplasia.</title>
      <link>http://hdl.handle.net/10147/246272</link>
      <description>Title: First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Authors: Alazzam, Mo'iad; Tidy, John; Hancock, Barry W; Osborne, Raymond; Lawrie, Theresa A
Abstract: This is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy. Most women with low-risk GTN will be cured by evacuation of the uterus with or without single-agent chemotherapy. However, chemotherapy regimens vary between treatment centres worldwide and the comparable benefits and risks of these different regimens are unclear.</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/246272</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Initial consecutive 125 cases of robotic assisted laparoscopic radical prostatectomy performed in Ireland's first robotic radical prostatectomy centre.</title>
      <link>http://hdl.handle.net/10147/228076</link>
      <description>Title: Initial consecutive 125 cases of robotic assisted laparoscopic radical prostatectomy performed in Ireland's first robotic radical prostatectomy centre.
Authors: Bouchier-Hayes, D M; Clancy, K X; Canavan, K; O'Malley, P J
Abstract: We examined the patient characteristics, operative proceedings and the outcomes of the initial series of 125 cases of robot-assisted laparoscopic radical prostatectomy (RALRP) in an independent hospital in Ireland, performed by two surgeons using the da Vinci(®) surgical system.</description>
      <pubDate>Thu, 01 Mar 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/228076</guid>
      <dc:date>2012-03-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Variations in the usage and composition of a radial cocktail during radial access coronary angiography procedures.</title>
      <link>http://hdl.handle.net/10147/223266</link>
      <description>Title: Variations in the usage and composition of a radial cocktail during radial access coronary angiography procedures.
Authors: Pate, G; Broderick, B
Abstract: A survey was conducted of medication administered during radial artery cannulation for coronary angiography in 2009 in Ireland; responses were obtained for 15 of 20 centres, in 5 of which no radial access procedures were undertaken. All 10 (100%) centres which provided data used heparin and one or more anti-spasmodics; verapamil in 9 (90%), nitrate in 1 (10%), both in 2 (20%). There were significant variations in the doses used. Further work needs to be done to determine the optimum cocktail to prevent radial artery injury following coronary angiography.</description>
      <pubDate>Sat, 01 Oct 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/223266</guid>
      <dc:date>2011-10-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

